Positive phase 3 efficacy and safety data were announced at EASD 2019 for a novel glucagon-like peptide-1 receptor agonist, polyethylene glycol loxenatide (PED168).
Compared with body mass index, waist circumference is a better indicator for obstructive coronary artery disease risk in postmenopausal women.
The AACE has produced a position statement addressing population-specific challenges and practical steps for clinicians with regard to diabetes care for African Americans, Latinx/Hispanics, Asian Americans, and Native Americans.
Body mass index partially mediates the relationship between early menarche and increased risk for type 2 diabetes.
The Endocrine Society published a clinical practice guideline cosponsored by the American Diabetes Association and the European Society of Endocrinology regarding the primary prevention of ASCVD and T2D.
With a growing number of patients with both diabetes and cardiovascular disease, clinicians consider the need for a new specialty: cardiometabolic medicine.
High-sensitivity troponins are elevated in some chronic conditions and may be useful markers for health status in older adults with diabetes.
Researchers analyzed patients who presented to an emergency department with chest pain and suspected acute coronary syndrome.
Researchers used coronary computed tomography angiography to determine whether the rate of coronary plaque progression is different in people with vs without diabetes.
PHILADELPHIA — Experts in the fields of endocrinology, cardiology, and nephrology will convene at the 3rd Annual Heart in Diabetes conference, held July 12 to 14, 2019, in Philadelphia, Pennsylvania, to discuss the latest data from major cardiovascular outcome trials and best practices to implement changing clinical practice guidelines into everyday care. An expected 400…
